Drawing for CELVERUM

USPTO serial 86214771

CELVERUM

Reviewed by CopyMark Law Group

Reg. 5906003Status 710
Filing date
Status date
Registration date
Nov 12, 2019
Examiner
HOWARD, PARKER WALDRIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CELVERUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

PATRICK J. CONCANNON NUTTER, MCCLENNEN & FISH, LLP155 SEAPORT BLVD, SEAPORT WBOSTON, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and substances for the for the treatment of cancer; pharmaceutical preparations and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disordersSECTION 8 - CANCELLED—
042scientific and medical research in the field of cancer; scientific and medical research in the field of pharmaceutical and therapeutic products and substances for the treatment of cancer; development of pharmaceutical and therapeutic products and substances for the treatment of cancer; testing and evaluation of pharmaceutical and therapeutic products and substances for the treatment of cancer; scientific and medical research in the field of immunological, inflammatory and auto-immune conditions, diseases and disorders; scientific and medical research in the field of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; development of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; testing and evaluation of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; scientific and medical research in the field of immunological, inflammatory and auto-immune conditions, diseases and disordersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026C8..CANCELLED SEC. 8 (6-YR)—
Nov 12, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 9, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 5, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 5, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 5, 2019CNSISUSPENSION INQUIRY WRITTEN—
Mar 27, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 25, 2019ALIEASSIGNED TO LIE—
Sep 7, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 7, 2018ALIEASSIGNED TO LIE—
Mar 7, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 7, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Mar 7, 2018CNSLSUSPENSION LETTER WRITTEN—
Feb 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 25, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 25, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 25, 2017CNSISUSPENSION INQUIRY WRITTEN—
Aug 10, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 6, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 6, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Feb 6, 2017CNSLSUSPENSION LETTER WRITTEN—
Feb 3, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 3, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 3, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 3, 2017CNSISUSPENSION INQUIRY WRITTEN—
Jan 30, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 27, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 27, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Jul 27, 2016CNSLSUSPENSION LETTER WRITTEN—
Jul 22, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 22, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 5, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 5, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Feb 5, 2016CNSLSUSPENSION LETTER WRITTEN—
Jan 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 14, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 14, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 14, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 1, 2015GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 1, 2015GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 1, 2015CNSISUSPENSION INQUIRY WRITTEN—
Jul 29, 2015RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 22, 2015ALIEASSIGNED TO LIE—
Jan 2, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 2, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jan 2, 2015CNSLSUSPENSION LETTER WRITTEN—
Dec 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 30, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2014DOCKASSIGNED TO EXAMINER—
Mar 20, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance